Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mission Bio is a life sciences company that developed the Tapestri Platform, the first single-cell multi-omics platform capable of simultaneously detecting DNA and protein from the same cell. This technology enables researchers and clinicians to identify rare cell populations and understand clonal heterogeneity in complex diseases like cancer. The platform is widely used in oncology research, hematology, and the development of cell and gene therapies to assess product consistency and quality. By providing high-resolution genomic and proteomic data, Mission Bio helps accelerate drug discovery and precision medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tapestri Platform.